Defeating malaria together

Isabelle Borghini-Fuhrer

Director, Product Development
Research & Development

What I do at MMV:

I lead the Pyramax project, which is MMV's second submission to the European Medicines Agency for regulatory approval.

Why I work at MMV:

To be able to use my competencies for a cause such as malaria and to take part in the development of a new antimalarial which will save lives is a huge motivation. In fact, for me it’s a privilege.

More about me:

I have extensive experience in clinical and medical research. Before joining MMV, I spent 10 years in clinical development in the biotech Industry, at Serono International SA, developing drugs for various indications in auto-immune diseases and hemato-oncology. Before that I spent 10 years in academia, working in hyperlipidemias and diabetes.

Ask me about:

Clinical development plans, clinical trials from design to set-up & implementation through to analysis and reporting, EMA’s Article 58 procedure, GCP inspections, partnerships.


Isabelle holds a PhD in Biochemistry from the University of Geneva.

Array ( [0] => front_not [1] => site_english [2] => view_rhs-column [3] => force_sidebars [4] => node_landing-pages_not [5] => node_staff-bio [6] => submenu [7] => view_related [8] => view_rhs-column-below [9] => view_rhs-column-top [10] => breadcrumb [11] => internal_adverts_desktop [12] => sitewide_desktop [13] => superfish_menu_desktop )